Chinese Traditional and Herbal Drugs
|
2025, 56(4): 1254-1265
Phloretin influences glutaminolysis-mediated prostate cancer by inhibiting PDK1-p-PDHA1 axis
Full
ZHAO Peng1, YANG Tuo1, WANG Jinzhu1, CAI Keke1, LIU Peng1, NIAN Xuewu2
Affiliations
1 Department of Urology Surgery, Tianjin Nankai hospital, Tianjin 300000, China;
2 Department of Urology Surgery, Tianjin Beichen Hospital, Tianjin 300400, China
doi: 10.7501/j.issn.0253-2670.2025.04.014
Outline
Objective To explore whether phloretin can affect the biological behavior of prostate cancer cells mediated by glutaminolysis by inhibiting pyruvate dehydrogenase kinase 1 (PDK1)-phosphorylation of pyruvate dehydrogenase E1 subunit alpha 1 (p-PDHA1). Methods Human prostate cancer cell lines PC-3, DU145, LNCaP, and human prostate epithelial cell line RWPE-1 were treated with different concentrations of phloretin (25, 50, 100 μmol/L), and cell proliferation was assessed using the cell counting kit-8 (CCK-8). PC-3 cells were divided into control (0.1% DMSO), phloretin (100 μmol/L), and cisplatin (DDP, 0.03 mmol/L) groups, and cell invasion was detected using the Transwell method while cell apoptosis was detected using the TUNEL method. PC-3 cells were treated with phloretin and/or glutamine (Gln) separately or in combination, and Gln levels, glutamate and adenosine triphosphate (ATP) production levels were measured using kits, while glutaminase 1 (GLS1) protein expression was determined by Western blotting in cell proliferation, invasion, and apoptosis were also assessed. Network pharmacology and bioinformatics were used to analyze the intersection of phloretin, prostate cancer, and Gln-related genes. Western blotting was used to measure PDK1 protein expression levels in RWPE-1, PC-3, and PC-3 + phloretin groups. Furthermore, The PC-3 cells were divided into control pcDNA3.1 group, pcDNA3.1-PDK1 group, the KD-PDK1 group and its control KD-Control group, pcDNA3.1-PDHA1 group, KD-PDK1 + pcDNA3.1-PDHA1 group and its control KD-PDK1 + pcDNA3.1 group, and phloretin + pcDNA3.1-PDK1 group and its control phloretin + pcDNA3.1 group, Changes in cell proliferation, invasion, apoptosis, Gln levels, glutamate and ATP production levels, and GLS1 protein expression in each group were measured. A prostate cancer xenograft mouse model was established, and phloretin intervention therapy was administered, with DDP treatment serving as a positive control, to investigate the effect of phloretin on tumor growth in vivo.Results Phloretin had no significant effect on the proliferation of RWPE-1 cells but significantly inhibited the proliferation of PC-3, DU145, and LNCaP cells, with the most significant effect on PC-3 cells at a concentration of 100 μmol/L (P < 0.05). Compared with control group, the phloretin group showed significantly reduced cell proliferation and invasion ability (P < 0.05), increased apoptosis levels (P < 0.05), decreased Gln levels, reduced glutamate and ATP production levels (P < 0.05), and weakened GLS1 protein expression (P < 0.05). Gln intervention yielded opposite results, and when phloretin and Gln were co-administered to PC-3 cells, phloretin inhibited the Gln-induced effects (P < 0.05). Network pharmacology and bioinformatics analysis indicated that PDK1 is one of the key targets for phloretin in the treatment of prostate cancer through the Gln metabolism pathway. Moreover, PDK1 was highly expressed in PC-3 cells and was inhibited by phloretin (P < 0.05). Compared with pcDNA3.1 group, overexpression of PDK1 in PC-3 cells promoted cell proliferation and invasion (P < 0.05), inhibited cell apoptosis (P < 0.05), but enhanced Gln metabolism in cells (P < 0.05). Compared with the phloretin + pcDNA3.1 group, overexpression of PDK1 partially reversed the effects of phlorizin on the biological behavior and Gln metabolism of PC-3 cells (P < 0.05). Additionally, compared with the KD-Control group, knockdown of PDK1 in PC-3 cells contributed to the inhibition of cell proliferation and invasion, promotion of cell apoptosis, and reduction of Gln metabolism levels. However, compared with the KD-PDK1 + pcDNA3.1 group, co-overexpression of PDHA1 reversed these effects (P < 0.05). In vivo experiments showed that phloretin significantly inhibited tumor growth in mice (P < 0.05). Conclusion Phloretin affects Gln metabolism-mediated prostate cancer progression by inhibiting the PDK1-PDHA1 axis.
phloretin
/
prostate cancer
/
pyruvate dehydrogenase kinase 1
/
pyruvate dehydrogenase E1 subunit alpha 1
/
glutaminolysis
赵朋, 杨拓, 王金铸, 蔡科科, 刘鹏, 念学武.
根皮素通过抑制PDK1-p-PDHA1轴影响谷氨酰胺代谢介导的前列腺癌研究.
中草药,
2025
, 56
(4)
: 1254
-1265
.
DOI: 10.7501/j.issn.0253-2670.2025.04.014
ZHAO Peng, YANG Tuo, WANG Jinzhu, CAI Keke, LIU Peng, NIAN Xuewu.
Phloretin influences glutaminolysis-mediated prostate cancer by inhibiting PDK1-p-PDHA1 axis[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(4)
: 1254
-1265
.
DOI: 10.7501/j.issn.0253-2670.2025.04.014
Year 2025 volume 56 Issue 4
48
9
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.04.014
- Receive Date:2024-09-18
- Online Date:2026-11-13